Status:
RECRUITING
Chronic Pain and Hemophilia
Lead Sponsor:
University Hospital, Clermont-Ferrand
Conditions:
Chronic Pain
Hemophilia
Eligibility:
All Genders
18+ years
Brief Summary
Hemophilia (A and B) are X-linked hereditary bleeding disorders whose severity depends on the level of coagulation factor (FVIII or FIX respectively). Bleeding is mainly from joints (hemarthrosis) and...
Detailed Description
This first French assessment of chronic pain in patients with haemophilia will permit to improve and generate new data about chronic pain related to haemophilia, associated-comorbidities, sociodemogra...
Eligibility Criteria
Inclusion
- Patient with haemophilia of any severity,
- Carrier female with low levels haemophilia (\< 40%),
- ≥ 18 years of age and capable of giving informed consent to participate in research.
Exclusion
- Patient's refusal to participate in the survey,
- Patient does not understand enough French (written and spoken) to complete the survey,
- Patient unable to complete the survey for logistical reasons (lack of internet access),
- Patient under protective measures (guardianship),
- Patients with known addictive comorbidities and/or cognitive disorders.
Key Trial Info
Start Date :
February 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT05202951
Start Date
February 28 2022
End Date
August 1 2026
Last Update
February 24 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux
Bordeaux, France
2
Centre Hospitalier Universitaire de Caen Normandie
Caen, France
3
CH Métropole Savoie
Chambéry, France
4
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000